Protein Characterization and Identification Market Report 2025

The protein characterization and identification market size has grown rapidly in recent years. It will grow from $18.93 billion in 2024 to $21.61 billion in 2025 at a compound annual growth rate (CAGR) of 14.1%. The growth in the historic period can be attributed to growth in proteomics research, focus on disease mechanisms, bioinformatics integration, protein structure determination, genomics to proteomics transition.

The protein characterization and identification market size is expected to see rapid growth in the next few years. It will grow to $39.82 billion in 2029 at a compound annual growth rate (CAGR) of 16.5%. The growth in the forecast period can be attributed to demand for bioinformatics solutions, rise in biopharmaceuticals, precision medicine growth, increased research funding, biomedical research expansion. Major trends in the forecast period include mass spectrometry advancements, proteomics in drug development, advancements in chromatography, automation and high-throughput methods, bioinformatics integration.

The rise in drug development activities is fueling the growth of the protein characterization and identification market. Drug development refers to the process of bringing a novel therapeutic molecule into clinical use. Accurate determination of protein quantities is essential in developing biopharmaceutical drugs and conducting various research projects, which is achieved through protein characterization and identification. Precise measurement of protein content is critical for establishing the drug product's dosage and quantifying other essential quality attributes. For example, in June 2024, the European Federation of Pharmaceutical Industries and Associations, a Belgium-based trade association, reported that the production value in the pharmaceutical industry rose from $385.1 million (€363.3 million) to an estimated $413.4 million (€390 million) between 2022 and 2023, indicating a significant increase in drug development activities. Thus, the surge in drug development initiatives is propelling the protein characterization and identification market.

Growing healthcare expenditure is anticipated to further boost the protein characterization and identification market in the coming years. Healthcare expenditure encompasses the consumption of resources aimed at promoting, restoring, and maintaining health. Rising healthcare spending enhances the protein characterization and identification sector by facilitating improved research techniques and expanding the industry. For instance, in May 2024, the Office for National Statistics, a UK-based executive office of the UK Statistics Authority, reported that UK healthcare expenditure reached approximately $370.8 billion (£292 billion) in 2023, reflecting a nominal increase of 5.6% from the previous year. Therefore, the upward trend in healthcare expenditure is driving the growth of the protein characterization and identification market.

A key trend in the protein characterization and identification market is product innovation, with major players introducing novel solutions. For example, in January 2023, SCIEX launched the Fast Glycan Labeling and Analysis kit and a software upgrade for the Biologics Explorer program. These innovations provide fast and accurate characterization of biotherapeutics, contributing to the ongoing trend of product innovation in the protein characterization and identification market.

Major companies in the protein characterization and identification market are concentrating on introducing innovative tools, such as mass spectrometers, to maintain a competitive edge. Mass spectrometers, analytical instruments measuring the mass-to-charge ratio of ions, find applications in various fields, including protein identification. In June 2023, Bruker Corporation launched the timsTOF Ultra Mass Spectrometer, incorporating transformative sensitivity and advanced features for protein characterization and identification. This reflects the industry's focus on developing cutting-edge tools to meet evolving needs.

In July 2024, Thermo Fisher Scientific, a US-based company specializing in life sciences and clinical research, acquired Olink Holding AB for $3.1 billion. This acquisition is intended to bolster Thermo Fisher's presence in the rapidly expanding proteomics sector by utilizing Olink's innovative proximity extension assay (PEA) technology. This strategic move will enhance Thermo Fisher’s current life sciences and mass spectrometry portfolio, facilitating advancements in protein biomarker discovery and precision medicine. Olink is a Sweden-based provider of next-generation proteomics solutions.

Major companies operating in the protein characterization and identification market include Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation, General Electric Company, The Merck Group, PerkinElmer Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc., Waters Corporation, Promega Corporation, Sartorius AG, Analytik Jena AG, Sigma-Aldrich Corp., Creative Proteomics, Cleaver Scientific, Genedata AG, Proteome Sciences plc, Selvita S.A., Eurofins Scientific SE, Charles River Laboratories International Inc., WuXi AppTec, Eurogentec S.A., Protea Biosciences Group Inc., Bioinformatics Solutions Inc., Biognosys AG, Bioproximity LLC, Biotech Support Group LLC, Biodesix Inc., SGS SA.

North America was the largest region in the protein characterization and identification market in 2024. The regions covered in the protein characterization and identification market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the protein characterization and identification market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Protein characterization and identification are integral parts of recombinant protein expression, involving the identification and characterization of final protein products. This process employs analytical methods and techniques to ensure the production of high-quality protein products.

The main types of protein characterization and identification components include consumables, instruments, and services. Consumables in protein characterization and identification are used for identifying and measuring protein substances, as well as detecting the presence or concentration of a protein in a solution through antibody-antigen reactions. These applications find use in drug discovery and development, as well as clinical diagnosis. End-users of protein characterization and identification products include pharmaceutical and biotechnology companies, academic research institutions, contract research organizations, and other related entities.

The protein characterization and identification market research report is one of a series of new reports that provides protein characterization and identification market statistics, including protein characterization and identification industry global market size, regional shares, competitors with a protein characterization and identification market share, detailed protein characterization and identification market segments, market trends and opportunities, and any further data you may need to thrive in the protein characterization and identification industry. This protein characterization and identification market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The protein characterization and identification market consists of revenues earned by entities by providing services such as quantitative proteomics, PTM (post-translational modifications) analysis, intact protein analysis, peptide mapping, therapeutics characterization, and biomarker discovery. The market value includes the value of related goods sold by the service provider or included within the service offering. The protein characterization and identification market also include sales of immunoassay consumables, mass spectrometry consumables, chromatography consumables, electrophoresis consumables, mass spectrometry instruments, chromatography instruments, electrophoresis instruments, label-free detection instruments, and spectroscopy instruments. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.